AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article

Biocompatible custom ceria nanoparticles against reactive oxygen species resolve acute inflammatory reaction after intracerebral hemorrhage

Dong-Wan Kang1,2,§, Chi Kyung Kim1,3,§, Han-Gil Jeong1,2,§, Min Soh4,5, Taeho Kim4,5, In-Young Choi1,2, Seul-Ki Ki1,2, Do Yeon Kim1,2, Wookjin Yang1,2, Taeghwan Hyeon4,5, Seung-Hoon Lee1,2( )
Laboratory of Innovative Nanobiotechnology, Biomedical Research InstituteSeoul National University HospitalSeoul03080Republic of Korea
Department of NeurologySeoul National University HospitalSeoul03080Republic of Korea
Department of NeurologyKorea University Guro Hospital and Korea University College of MedicineSeoul08308Republic of Korea
Center for Nanoparticle ResearchInstitute for Basic Science (IBS)Seoul151-742Republic of Korea
School of Chemical and Biological Engineering and Institute of Chemical ProcessesSeoul National UniversitySeoul151-742Republic of Korea

§These authors contributed equally to this work.

Show Author Information

Abstract

Intracerebral hemorrhage (ICH) is a devastating subtype of stroke with a high mortality rate, for which there currently is no effective treatment. A perihematomal edema caused by an intense inflammatory reaction is more deleterious than the hematoma itself and can result in neurological deterioration and death. Ceria nanoparticles (CeNPs) are potent free radical scavengers with potential for biomedical applications. As oxidative stress plays a major role in post-ICH inflammation, we hypothesized that CeNPs might protect against ICH. To test this hypothesis, core CeNPs were synthesized using a modified reverse micelle method and covered with phospholipid-polyethylene glycol (PEG) to achieve biocompatibility. We investigated whether our custom-made biocompatible CeNPs have protective effects against ICH. The CeNPs reduced oxidative stress, hemin-induced cytotoxicity, and inflammation in vitro. In a rodent ICH model, intravenously administered CeNPs were mainly distributed in the hemorrhagic hemisphere, suggesting that they could diffuse through the damaged blood–brain barrier. Moreover, CeNPs attenuated microglia/macrophage recruitment around the hemorrhagic lesion and inflammatory protein expression. Finally, CeNP treatment reduced the brain edema by 68.4% as compared to the control. These results reveal the great potential of CeNPs as a novel therapeutic agent for patients with ICH.

Graphical Abstract

Electronic Supplementary Material

Download File(s)
nr-10-8-2743_ESM.pdf (2.8 MB)

References

【1】
【1】
 
 
Nano Research
Pages 2743-2760

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Kang D-W, Kim CK, Jeong H-G, et al. Biocompatible custom ceria nanoparticles against reactive oxygen species resolve acute inflammatory reaction after intracerebral hemorrhage. Nano Research, 2017, 10(8): 2743-2760. https://doi.org/10.1007/s12274-017-1478-6

1254

Views

48

Crossref

N/A

Web of Science

49

Scopus

4

CSCD

Received: 28 June 2016
Revised: 04 January 2017
Accepted: 09 January 2017
Published: 09 January 2017
© Tsinghua University Press and Springer-Verlag Berlin Heidelberg 2017